1H NMR (400 MHz, CDCl3): d 1.77 (6H, s, CH3), 2.30 (6H, s,
CH3), 7.20 (2H, s, Ar), 7.22 (2H, s, Ar). 13C NMR (100 MHz,
CDCl3): d 20.6 (s), 20.7 (s), 97.5 (s), 103.0 (s), 124.4 (s), 129.8
(s), 132.5 (s), 134.4 (s), 153.8 (s). m/z (ESI+): 425 [M + H]+,
447 [M + Na]+.
(6H, s, CH3), 3.88–3.90 (1H, m, CH), 6.33–6.34 (1H, m, CH),
4
4
6.93 (2H, d, JH–H = 1.72 Hz, Ar), 7.17 (2H, d, JH–H = 1.52 Hz,
Ar); 13C NMR (100 MHz, CDCl3): d 20.4 (s), 25.4 (s), 32.2 (s),
92.9 (s), 110.3 (s), 127.2 (s), 127.3 (s), 132.2 (s), 132.5 (s), 145.8 (s).
m/z (ESI+): 432.9 [M + Na]+.
1,6-Bis(diphenylphosphino)-5a,10b-dihydro-5a,10b-dimethyl-3,
8-dimethylbenzofuro[3,2-b]benzofuran (7). Ligand 7 was pre-
pared following the same synthetical procedure described above
for compound 4, but using compound 6 as dibrominated precur-
sor. Yield: 62%. (Found: C, 78.00; H, 6.48. C42H36 O2P2 requires
C, 79.48; H, 5.72%). 1H NMR (400 MHz, CDCl3): d 1.58 (6H, s,
2,10-Dimethyl-4,8-diphenylphosphino-6,12-methano-12H-di-
benzo[2,1-d:l¢,2¢¢-g][l,3]dioxocin (13). Ligand 13 was prepared
following the same synthetical procedure described above for
compound 4, but using compound 12 as dibrominated precursor.
Yield: 86%. (Found: C, 79.15; H, 5.57. C41H34O2P2 requires C,
1
79.34; H, 5.52%). H NMR (400 MHz, CDCl3): d 2.09 (2H, t,
3JH–H = 2.48 Hz, CH2), 2.11 (6H, s, CH3), 3.89–3.92 (1H, m, CH),
3
4
CH3), 2.10 (6H, s, CH3), 6.50 (2H, dd, JH–P = 6.2 and JH–H
=
4
3
4
1.3 Hz, Ar), 6.80 (2H, d, JH–H = 1.32 Hz), 7.15–7.33 (20H, m,
5.88–5.90 (1H, m, CH), 6.32 (2H, dd, JH–P = 4.8 and JH–H =
Ar); 31P { H} NMR (162 MHz, CDCl3): d -12.9 (s); 13C NMR
1.9 Hz, Ar), 7.02 (2H, d, 4JH–H = 1.72 Hz, Ar), 7.19–7.35 (20H, m,
1
1
(100 MHz, CDCl3): d 20.7 (s), 21.0 (s), 95.9 (d, JC–P = 1.5 Hz),
118.2 (d, JC–P = 13.9 Hz), 126.5 (s), 128.2 (d, JC–P = 6.6 Hz), 128.4
(d, JC–P = 6.6 Hz), 128.5 (s), 128.7 (s), 129.1 (d, JC–P = 2.2 Hz),
Ar); 31P { H} NMR (162 MHz, CDCl3): d -12.8 (s); 13C NMR
(100 MHz, CDCl3): d 20.8 (s), 25.7 (s), 32.2 (s), 92.2 (s), 124.6 (d,
JC–P = 15.4 Hz), 126.1 (d, JC–P = 2.2 Hz), 128.4 (d, JC–P = 4.9 Hz),
128.5 (d, JC–P = 3.6 Hz), 128.6 (s), 129.0 (s), 130.6 (d, JC–P = 1.5 Hz),
130.6 (d, JC–P = 2.2 Hz), 133.6 (d, JC–P = 19.7 Hz), 134.1 (d, JC–P
=
20.5 Hz), 135.0 (d, JC–P = 7.3 Hz), 136.2 (d, JC–P = 8.1 Hz), 136.3
(d, JC–P = 7.3 Hz), 158.2 (d, JC–P = 13.2 Hz). m/z (ESI+): 635 [M +
H]+, 657 [M + Na]+. HR-MS: (ESI+) m/z for C42H36O2P2Na ([M +
Na]+) 657.2088; found 657.2112.
133.0 (d, JC–P = 1.5 Hz), 133.8 (d, JC–P = 19.8 Hz), 134.1 (d, JC–P =
20.5 Hz), 136.8 (d, JC–P = 11.3 Hz), 137.1 (d, JC–P = 11.4 Hz), 150.9
(d, JC–P = 15.0 Hz). m/z (ESI+): 621 [M + H]+, 643 [M + Na]+.
HR-MS: (ESI+) m/z for C41H34O2P2Na ([M + Na]+) 643.1932;
found 643.1935.
4,7-Dibromo-5a,10b-dihydro-2,9-dimethylbenzofuro[2,3-b]-
benzofuran (9). Compound 9 was prepared using the same
procedure described above for compound 3, but using 5a,10b-
dihydro-2,9-dimethylbenzofuro[2,3-b]benzofuran 8 as substrate to
brominate. Yield: 69%. (Found: C, 48.47; H, 3.09. C16H12Br2O2
2,10-Di-tert-butyl-6,12-methano-12H-dibenzo[2,1-d:l¢,2¢¢-g]-
[l,3]dioxocin (14). To a stirred solution of 4-tert-butylphenol
(20.48 g, 136.3 mmol) in trifluoroacetic acid (42 ml), was added
1,1,3,3-tetramethoxypropane (11.5 ml, 69.5 mmol) and left stirring
overnight at r.t. After addition of acetic acid (80 ml), the crude
product was collected by filtration, washed with methanol and
finally boiled with water to afford after filtration 14 (8.6 g, 37%) as
a white-pink solid. (Found: C, 77.44; H, 8.11. C17H14Br2O2 requires
C, 82.10; H, 8.39%). 1H NMR (400 MHz, CDCl3): d 1.28 (18H, m,
tBu, 2.25 (2H, m, CH2), 3.90–3.96 (1H, m, CH), 6.10–6.15 (1H,
1
requires C, 48.52; H, 3.05%). H NMR (400 MHz, CDCl3): d
2.29 (6H, s, CH3), 5.09 (1H, d, 3JH–H = 6.7 Hz, CH), 6.95 (1H, d,
3JH–H = 6.7 Hz, CH), 7.07 (2H, s, Ar), 7.14 (2H, s, Ar); 13C NMR
(100 MHz, CDCl3): d 20.6 (s), 52.1 (s), 102.6 (s), 112.2 (s), 123.4
(s), 127.8 (s), 132.6 (s), 133.4 (s), 153.3 (s). m/z (ESI+): 419 [M +
Na]+.
3
3
m, CH), 6.82 (2H, d, JH–H = 8.5 Hz, Ar), 7.11 (2H, d, JH–H
=
4,7-Bis(diphenylphosphino)-5a,10b-dihydro-2,9-dimethylbenzo-
furo[2,3-b]benzofuran (10). Ligand 10 was prepared following the
same synthetical procedure described above for compound 4, but
using compound 9 as dibrominated precursor. Yield: 50%. (Found:
8.5 Hz, Ar), 7.20 (2H, s, Ar); 13C NMR (100 MHz, CDCl3): d 25.9
(s), 31.7 (s), 32.5 (s), 34.3 (s), 92.4 (s), 116.0 (s), 124.3 (s), 125.0 (s),
126.3 (s), 144.2 (s), 148.9 (s). m/z (ESI+): 359.2 [M + Na]+.
1
C, 78.58; H, 5.57. C40H32O2P2 requires C, 79.20; H, 5.32%). H
4,8-Dibromo-2,10-di-tert-butyl-6,12-methano-12H -dibenzo-
[2,1-d:l¢,2¢¢-g][l,3]dioxocin (15). Compound 15 was prepared us-
ing the same procedure described above for compound 3, but using
compound 14 as substrate to brominate. Yield: 90%. (Found: C,
55.56; H, 5.42. C23H26Br2O2 requires C, 55.89; H, 5.30%). 1H NMR
(400 MHz, CDCl3): d 1.26 (18H, s, tBu), 2.26 (2H, t, 3JH–H = 2.5 Hz,
CH2), 3.95–3.98 (1H, m, CH), 6.33–6.36 (1H, m, CH), 7.12 (2H,
NMR (400 MHz, CDCl3): d 2.18 (6H, s, CH3), 4.91 (1H, d,
3JH–H = 6.7 Hz, CH), 6.52 (2H, d, 3JH–P = 5.6 Hz, Ar), 6.74 (1H, d,
3JH–H = 6.7 Hz, CH), 7.17 (2H, s, Ar), 7.26–7.34 (20H, m, Ar); 31
P
1
{ H} NMR (162 MHz, CDCl3): d -14.4 (s); 13C NMR (100 MHz,
CDCl3): d 21.1 (s), 50.2 (s), 112.7 (s), 118.3 (d, JC–P = 16.9 Hz),
125.5 (s), 127.0 (d, JC–P = 2.6 Hz), 128.4 (d, JC–P = 4.3 Hz), 128.5
4
4
(d, JC–P = 4.4 Hz), 128.7 (d, JC–P = 18.4 Hz), 131.7 (d, JC–P
1.9 Hz), 133.7 (d, JC–P = 20.1 Hz), 133.8 (s), 134.0 (d, JC–P
=
=
d, JH–H = 2.04 Hz, Ar), 7.35 (2H, d, JH–H = 2.04 Hz, Ar); 13C
NMR (100 MHz, CDCl3): d 25.4 (s), 31.4 (s), 31.5 (s), 32.8 (s),
34.4 (s), 93.0 (s), 110.2 (s), 123.6 (s), 127.2 (s), 129.2 (s), 145.7 (s),
145.8 (s). m/z (ESI+): 517 [M + Na]+.
20.5 Hz), 136.2 (d, JC–P = 4.4 Hz), 136.3 (d, JC–P = 4.4 Hz), 158.6 (d,
JC–P = 14.9 Hz). m/z (ESI+): 607 [M + H]+, 629 [M + Na]+. HR-
MS: (ESI+) m/z for C40H32O2NaP2 ([M + Na]+) 629.1775, found
629.1776.
2,10-Di-tert-butyl-4,8-diphenylphosphino-6,12-methano-12H-
dibenzo[2,1-d:l¢,2¢¢-g][l,3]dioxocin (16). Ligand 16 was prepared
following the same synthetical procedure described above for
compound 4, but using compound 15 as dibrominated precursor.
Yield: 66%. (Found: C, 77.69; H, 6.81. C47H46O2P2 requires C,
4,8-Dibromo-2,10-dimethyl-6,12-methano-12H-dibenzo[2,1-d:
l¢,2¢¢-g][l,3]dioxocin (12). Compound 12 was prepared using the
same procedure described above for compound 3, but using
2,10-dimethyl-6,12-methano-12H-dibenzo[2,1-d:l¢,2¢¢-g][l,3] diox-
ocin 11 as substrate to brominate. Yield: 87%. (Found: C, 49.91;
H, 3.18. C17H14Br2O2 requires C, 49.79; H, 3.44%). 1H NMR
1
80.09; H, 6.58%). H NMR (400 MHz, CDCl3): d 1.08 (18H, s,
tBu), 2.10 (2H, t, 3JH–H = 2.46 Hz, CH2), 3.93–3.97 (1H, m, CH),
5.87–5.90 (1H, m, CH), 6.53 (2H, dd, 3JH–P = 5.4 and 4JH–H = 2.4 Hz,
3
4
(400 MHz, CDCl3): d 2.22 (2H, t, JH–H = 2.64 Hz, CH2), 2.24
Ar), 7.19 (2H, d, JH–H = 2.3 Hz, Ar), 7.26–7.34 (20H, m, Ar);
8570 | Dalton Trans., 2010, 39, 8560–8574
This journal is
The Royal Society of Chemistry 2010
©